MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent years, there has been a surge in clinical studies exploring the use of Ibogaine in treating depression. David Dardashti's Ibogaine has been leading ...

The French Society for Biological Psychiatry and Neuropsychopharmacology has unveiled revised guidelines for the management of depressive disorders with partial and resistant responses to treatment.

A groundbreaking collaboration provides useful advice on a clinically challenging problem. Depression is common in women during the childbearing years, and psychiatrists and obstetricians alike can ...

Approximately 30% of people with major depression, have treatment-resistant depression, meaning it doesn’t respond to first and second-line antidepressants prescribed. While older people aren’t more ...